Show simple item record

A novel 3D-printed brachytherapy applicator and monte Carlo model for the treatment of conjunctival tumors

dc.contributor.authorMatrosic, CK
dc.contributor.authorKronenberg, S
dc.contributor.authorDemirci, H
dc.contributor.authorHayman, JA
dc.contributor.authorHan, H
dc.contributor.authorLee, C
dc.coverage.spatialUnited States
dc.date.accessioned2024-09-06T17:11:11Z
dc.date.available2024-09-06T17:11:11Z
dc.date.issued2024-01-01
dc.identifier.issn1538-4721
dc.identifier.issn1873-1449
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pubmed/39181747
dc.identifier.urihttps://hdl.handle.net/2027.42/194949en
dc.description.abstractPURPOSE: To develop a custom low dose rate brachytherapy applicator for the treatment of conjunctival malignancies which leverages 3D-printing technology to provide enhanced design flexibility and availability. METHODS: An elliptical shell applicator inspired by ocular surgery postoperation conformer shells was developed for the placement of the applicator around the cornea of the eye, with a central hole to provide patient comfort. The applicator featured 2 concentric circles of slots for iodine-125 seeds, providing customization of the dose distribution depending on the location of the target. The applicator was modeled using computer-aided design software. The resultant model STL file was used for 3D printing of the applicator and the development of a Monte Carlo model of the applicator and its dose distribution. RESULTS: The applicator was successfully 3D printed using biocompatible resin, which could be sterilized for treatment after manual source loading. A Geant4 model of the applicator was created directly from the STL model and was applied to a phantom to estimate the dose distribution delivered by the applicator. The toroidal dose distribution allowed for treatment of the conjunctiva while reducing dose to the cornea compared to traditional eye plaque designs. CONCLUSIONS: A custom 3D-printed applicator was successfully developed and modeled for the treatment of conjunctival malignancies. This novel applicator design potentially provides higher quality, more customizable dose distributions for patients and the simplicity of the design makes it accessible for any clinic with 3D-printing technology.
dc.format.mediumPrint-Electronic
dc.languageeng
dc.publisherElsevier BV
dc.subject3D printing
dc.subjectConjunctival tumors
dc.subjectEye plaques
dc.subjectMonte Carlo
dc.titleA novel 3D-printed brachytherapy applicator and monte Carlo model for the treatment of conjunctival tumors
dc.typeArticle
dc.identifier.pmid39181747
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/194949/2/1-s2.0-S1538472124001120.pdf
dc.identifier.doi10.1016/j.brachy.2024.07.004
dc.identifier.doihttps://dx.doi.org/10.7302/24192
dc.identifier.sourceBrachytherapy
dc.description.versionPublished version
dc.date.updated2024-09-06T17:11:09Z
dc.identifier.orcid0000-0002-4075-8567
dc.identifier.orcid0009-0003-3299-0109
dc.identifier.orcid0000-0003-1593-1476
dc.identifier.orcid0000-0003-1391-5608
dc.identifier.orcid0000-0002-5769-5945
dc.description.filedescriptionDescription of 1-s2.0-S1538472124001120.pdf : Accepted version
dc.identifier.startpageS1538-4721(24)00112-0
dc.identifier.name-orcidMatrosic, CK; 0000-0002-4075-8567
dc.identifier.name-orcidKronenberg, S; 0009-0003-3299-0109
dc.identifier.name-orcidDemirci, H; 0000-0003-1593-1476
dc.identifier.name-orcidHayman, JA; 0000-0003-1391-5608
dc.identifier.name-orcidHan, H
dc.identifier.name-orcidLee, C; 0000-0002-5769-5945
dc.working.doi10.7302/24192en
dc.owningcollnameRadiation Oncology, Department of


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.